Search Login Register

RV 538 (PDMP) Summary

Description: noninactivating inhibitor of ceramide-UDPG glucosyltransferase; RN given for unspecified HCl; structure given in first source

Also Known As: PDMP; 1-phenyl-2-decanoylamino-3-morpholino-1-propanol; 2-decanoylamino-3-morpholino-1-phenylpropanol; DAMPP; RV 538, (R-(R*,R*))-isomer Show All >>

Networked: 89 relevant articles (7 outcomes, 11 trials/studies) for this Bio-Agent

Key Diseases for which RV 538 is Relevant

  1. Neoplasms (Cancer) : 1 outcome 1 study in 14 results
  2. Atherosclerosis : 1 outcome 1 study in 6 results
  3. Pain (Aches) : 1 outcome 1 study in 6 results
  4. Ischemia : 1 outcome 1 study in 6 results
  5. Cardiomegaly (Heart Hypertrophy) : 1 outcome 1 study in 2 results
Show All >>

Drugs Related to RV 538

  1. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
  2. Opioid Analgesics (Opioids)
  3. CDw17 antigen (lactosylceramide)
  4. Polymers
  5. G(M3) Ganglioside
  6. ceramide trihexoside
  7. ceramide glucosyltransferase
  8. P-Glycoprotein
  9. Paclitaxel (Taxol)
  10. Daunorubicin (Cerubidine)
Show All >>

Therapies Related to RV 538

  1. Life Support Care
  2. Renal Dialysis (Hemodialysis)
  3. Stents
  4. Drug Therapy (Chemotherapy)

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.